# Understanding the PKCε Inhibitor Peptide: A Technical Overview
In the realm of advanced biochemical research and peptide synthesis, the PKCε inhibitor peptide has emerged as a cornerstone tool for researchers investigating the complex signaling pathways of the Protein Kinase C (PKC) family. Having spent significant time experimenting with various synthetic peptides for laboratory modeling, I have found that grasping the specific mechanism of action—namely the prevention of enzyme translocation—is essential for any rigorous study.
The molecule most commonly referred to by researchers is the PKCε inhibitor peptide, also known as εV1-2. This is an octapeptide with the sequence EAVSLKPT, which acts as a highly selective tool for disrupting the interaction between the enzyme and its specific intracellular binding partner, RACK2 (Receptor for Activated C Kinase 2).
From my perspective as an enthusiast of peptide chemistry, the specificity of this octapeptide is its most impressive feature. By mimicking the binding site of the enzyme, it prevents the PKC epsilon translocation process, effectively keeping the kinase in its inactive or non-localized state. This is distinct from broad-spectrum inhibitors; it does not simply block the catalytic site but instead preve (PDF) The Multifaceted Role of Protein Kinase C Epsilon (PKCε) in nts the enzyme from ever reaching its subcellular target sites.
Variations and Enhanced Delivery
In my personal experience working with these materials, I have noted that the standard peptide Activators and Inhibitors of Protein Kinase C (PKC): … sometimes faces challenges with cellular uptake. To overcome these, manufacturers often supply the myris PKCε Inhibitor Peptide (Protein Kinase Cɛ Inhibitor Peptide, ɛV1-2, … toylated PKCε inhibitor peptide. By attaching a myristoyl group to the peptide sequence (Myr-EAVSLKPT), the molecule gains significant cell permeability, allowing it to transition across the lipid bilayer with much greater efficiency than the unconjugated version.
Furthermore, some advanced experimental designs have utilized dual-conjugation, such as linking both myristoylation and Tat-sequences to boost intracellular concentration. This highlights the ongoing innovation in how we modulate protein activity in vitro.
Key Technical Specifications
When sourcing these compounds, accuracy is paramount. The following parameters are generally consistent across high-quality batches:
* CAS Number: 182683-50-7
* Sequence: Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr
* Molecular Target: Protein Kinase C epsilon (PKCε)
* Primary Function: Selective inhibition of translocation to RACK2
For those performing control experiments, it is vital to utilize the PKCε translocation inhibitor peptide - negative control. This control peptide is designed to match the physical characteristics of the active inhibitor without the specific binding affinity for RACK2, ensuring that any observed cellular responses are due to actual PKCε inhibition rather than secondary effects of the peptide structure.
Exploring the Scientific Landscape
The Protein Kinase C epsilon is a critical focus for many studying cellular dynamics. When searching for information, I have noted frequent interest rega PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … rding PKC peptide inhibitors and how they function compared to small molecule inhibitors. These peptides are invaluable because they provide a level of spatial control that standard inhibitors often lack.
W pkc ii-peptide-inhibitor-i related products. MedChemExpress (MCE) provides thousands of inhibitors, modulators and agonists with … hether you are looking at PKC epsilon inhibitors for basic signal transduction mapping or evaluating epsilon-V1-2 for specific receptor-binding disruption, the data suggests that these peptides are highly replicable tools. Integrating them into a localized experiment requires careful titration, as the concentrations required to block epsilon-PKC mediated signaling can vary depending on the target cell line or tissue type.
Final Thoughts on Peptide Selection
When selecting high-purity peptides, one must consider the synthesis method. Peptides derived from the C2 domain of PKC enzymes exhibit high affinity, but their stability can be a factor. I always recommend sourcing from vendors who provide high-performance liquid chromatography (HPLC) profiles to ensure the integrity of the sequence. For those of PKCε Inhibitor Peptide,Myristoylated; (Myristoyl)EAVSLKPT-OH us epsilon-V1-2, epsilon-PKC Inhibitor - CPC Scientific deeply invested in the mechanics of signal pkc ii-peptide-inhibitor-i related products. MedChemExpress (MCE) provides thousands of inhibitors, modulators and agonists with … proteins, having a reliable mechanism to halt translocation is the gold standard for verifying the biological role of kinase pathways in a controlled environment. By understanding the structural design and the nuances of the PKCε inhibitor peptide, researchers can better navigate the intricate architecture of cellular signaling.
# Understanding the PKCε Inhibitor Peptide: A Technical Overview
In the realm of advanced biochemical research and peptide synthesis, the PKCε inhibitor peptide has emerged as a cornerstone tool for researchers investigating the complex signaling pathways of the Protein Kinase C (PKC) family. Having spent significant time experimenting with various synthetic peptides for laboratory modeling, I have found that grasping the specific mechanism of action—namely the prevention of enzyme translocation—is essential for any rigorous study.
The molecule most commonly referred to by researchers is the PKCε inhibitor peptide, also known as εV1-2. This is an octapeptide with the sequence EAVSLKPT, which acts as a highly selective tool for disrupting the interaction between the enzyme and its specific intracellular binding partner, RACK2 (Receptor for Activated C Kinase 2).
From my perspective as an enthusiast of peptide chemistry, the specificity of this octapeptide is its most impressive feature. By mimicking the binding site of the enzyme, it prevents the PKC epsilon translocation process, effectively keeping the kinase in its inactive or non-localized state. This is distinct from broad-spectrum inhibitors; it does not simply block the catalytic site but instead preve (PDF) The Multifaceted Role of Protein Kinase C Epsilon (PKCε) in nts the enzyme from ever reaching its subcellular target sites.
Variations and Enhanced Delivery
In my personal experience working with these materials, I have noted that the standard peptide Activators and Inhibitors of Protein Kinase C (PKC): … sometimes faces challenges with cellular uptake. To overcome these, manufacturers often supply the myris PKCε Inhibitor Peptide (Protein Kinase Cɛ Inhibitor Peptide, ɛV1-2, … toylated PKCε inhibitor peptide. By attaching a myristoyl group to the peptide sequence (Myr-EAVSLKPT), the molecule gains significant cell permeability, allowing it to transition across the lipid bilayer with much greater efficiency than the unconjugated version.
Furthermore, some advanced experimental designs have utilized dual-conjugation, such as linking both myristoylation and Tat-sequences to boost intracellular concentration. This highlights the ongoing innovation in how we modulate protein activity in vitro.
Key Technical Specifications
When sourcing these compounds, accuracy is paramount. The following parameters are generally consistent across high-quality batches:
* CAS Number: 182683-50-7
* Sequence: Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr
* Molecular Target: Protein Kinase C epsilon (PKCε)
* Primary Function: Selective inhibition of translocation to RACK2
For those performing control experiments, it is vital to utilize the PKCε translocation inhibitor peptide - negative control. This control peptide is designed to match the physical characteristics of the active inhibitor without the specific binding affinity for RACK2, ensuring that any observed cellular responses are due to actual PKCε inhibition rather than secondary effects of the peptide structure.
Exploring the Scientific Landscape
The Protein Kinase C epsilon is a critical focus for many studying cellular dynamics. When searching for information, I have noted frequent interest rega PKCε Inhibitor Peptide, also called εV1-2, is a protein kinase C ε (PKCε)-derived peptide, act as a selective PKCε inhibitor, inhibits … rding PKC peptide inhibitors and how they function compared to small molecule inhibitors. These peptides are invaluable because they provide a level of spatial control that standard inhibitors often lack.
W pkc ii-peptide-inhibitor-i related products. MedChemExpress (MCE) provides thousands of inhibitors, modulators and agonists with … hether you are looking at PKC epsilon inhibitors for basic signal transduction mapping or evaluating epsilon-V1-2 for specific receptor-binding disruption, the data suggests that these peptides are highly replicable tools. Integrating them into a localized experiment requires careful titration, as the concentrations required to block epsilon-PKC mediated signaling can vary depending on the target cell line or tissue type.
Final Thoughts on Peptide Selection
When selecting high-purity peptides, one must consider the synthesis method. Peptides derived from the C2 domain of PKC enzymes exhibit high affinity, but their stability can be a factor. I always recommend sourcing from vendors who provide high-performance liquid chromatography (HPLC) profiles to ensure the integrity of the sequence. For those of PKCε Inhibitor Peptide,Myristoylated; (Myristoyl)EAVSLKPT-OH us epsilon-V1-2, epsilon-PKC Inhibitor - CPC Scientific deeply invested in the mechanics of signal pkc ii-peptide-inhibitor-i related products. MedChemExpress (MCE) provides thousands of inhibitors, modulators and agonists with … proteins, having a reliable mechanism to halt translocation is the gold standard for verifying the biological role of kinase pathways in a controlled environment. By understanding the structural design and the nuances of the PKCε inhibitor peptide, researchers can better navigate the intricate architecture of cellular signaling.